💊 #FDA Drug Approvals — September 2026
#Lirafugratinib, #Isembyld & #Zanvastro bring new approaches targeting FGFR, myostatin & RNA.

#Sevabertinib, #Camizestrant, #Imlunestrant, #Aqneursa & #Joenja expand therapeutic options across cancer, rare diseases & genetic disorders.

🎯#FDA approves #camizestrant (#Etcamah, AstraZeneca) + a CDK4/6 inhibitor for #ESR1-mutated HR+/HER2− advanced or metastatic breast cancer, using ctDNA to detect emerging resistance and guide a targeted treatment switch.

#FDAApproval #BreastCancer #ctDNA #PrecisionMedicine #Oncology

HR陽性乳がんのETCAMAH併用療法を米国で承認──SERENA-6試験のPFS改善効果と適応対象を整理
stellanews.life/technology/1... #camizestrant #SERENA-6